A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis

Br J Cancer. 2001 Jul 20;85(2):176-81. doi: 10.1054/bjoc.2001.1880.

Abstract

Hereditary multiple exostoses (EXT) is an autosomal dominant disease characterized by the formation of cartilage-capped prominences (exostoses) that develop from the juxta-epiphyseal regions of the long bones. 3 genes are known to be involved in the formation of exostoses. Among them, EXT1 and EXT2, which encode enzymes that catalyse the biosynthesis of heparan sulfate, an important component of the extracellular matrix, are responsible for over 70% of the EXT cases. A large Chinese family with hereditary multiple exostoses has been analysed and the disease-causing mutation has been found. Blood samples were obtained from 69 family members, including 23 affected individuals. The EXT phenotype was shown to be linked to the EXT2 gene by using 2-point linkage analysis. After polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) analysis and DNA sequencing, a previously unreported deletion of a G in exon 3 of EXT2 gene was observed. This deletion co-segregated with the disease phenotype, suggesting that it is the disease-causing mutation in this family. Furthermore, in at least 4 members chondrosarcoma occurred after either an operation or injury of the exostosis and 3 of them died of the malignancy in the family. Whether the operation or injury was responsible for the malignant transformation still needs further study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • China
  • DNA Primers
  • Exostoses, Multiple Hereditary / ethnology
  • Exostoses, Multiple Hereditary / genetics*
  • Female
  • Gene Deletion*
  • Genetic Linkage
  • Humans
  • Male
  • Mutation*
  • N-Acetylglucosaminyltransferases*
  • Pedigree
  • Polymorphism, Single-Stranded Conformational
  • Proteins / genetics*

Substances

  • DNA Primers
  • Proteins
  • N-Acetylglucosaminyltransferases
  • exostosin-2